Loading…
Sectoral / Thematic · quant Mutual Fund · AMFI code 148560quant ESG Integration Strategy Fund
Disclosed for 71 months, Nov 2020 to Sep 2026.
Portfolio value
₹334 Cr
up ₹19.2 Cr vs Jul 2024
- Stocks held
- 11
- down 6 vs Jul 2024
- Top 10 weight
- 72.6%
quant ESG Integration Strategy Fund is an active equity fund in the Sectoral / Thematic category from quant Mutual Fund. In August 2024 it disclosed 11 stocks worth ₹334 Cr, up ₹19.2 Cr from Jul 2024. Its largest positions were Aurobindo Pharma Limited (8.7%), Pfizer Limited (8.1%), Dr. Reddy's Laboratories Limited (8.0%); the ten largest together made up 72.6% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 39.6% of its equity. Cash and debt stood at 15.0%. Compared with Jul 2024 the fund entered 1 new stock and exited 7.
Against 229 other Sectoral / Thematic funds
Concentration
94%
Top-10 weight is higher than 94% of peers
Breadth
0%
Holds more stocks than 0% of peers
Cash
98%
Holds more cash than 98% of peers
What these mean: concentration · cash
Holdings in August 2024
Download CSVEvery line the fund disclosed, with the change against Jul 2024. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Cash, TREPS & receivables | 14.98% | up 13.36 pts | ₹50 Cr | up ₹44.9 Cr | Added |
| Aurobindo Pharma Limited | 8.74% | up 0.27 pts | ₹29.2 Cr | up ₹2.5 Cr | Added |
| Pfizer Limited | 8.08% | up 0.09 pts | ₹27 Cr | up ₹1.8 Cr | Added |
| Dr. Reddy's Laboratories Limited | 8.00% | down 0.15 pts | ₹26.7 Cr | up ₹1.1 Cr | Added |
| Zydus Wellness Limited | 7.97% | up 0.66 pts | ₹26.6 Cr | up ₹3.6 Cr | Added |
| Life Insurance Corporation Of India | 7.97% | down 1.37 pts | ₹26.6 Cr | down ₹2.8 Cr | Trimmed |
| Britannia Industries Limited | 7.10% | down 0.34 pts | ₹23.7 Cr | up ₹29 L | Added |
| Aditya Birla Fashion and Retail Limited | 6.99% | down 0.48 pts | ₹23.3 Cr | down ₹16 L | Trimmed |
| HDFC Life Insurance Company Limited | 6.86% | down 0.19 pts | ₹22.9 Cr | up ₹72 L | Added |
| Divi's Laboratories Limited | 5.49% | down 0.14 pts | ₹18.3 Cr | up ₹61 L | Added |
| Bajaj Finance Limited 26/09/2024 Derivative | 5.43% | up 5.43 pts | ₹18.1 Cr | up ₹18.1 Cr | New |
| HFCL Limited | 4.75% | up 4.75 pts | ₹15.9 Cr | up ₹15.9 Cr | New |
| Marico Limited | 4.65% | down 0.49 pts | ₹15.5 Cr | down ₹65 L | Trimmed |
| Divi's Laboratories Limited 26/09/2024 Derivative | 2.98% | up 2.98 pts | ₹10 Cr | up ₹10 Cr | New |
What changed, Jul 2024 to Aug 2024
New New positions (1)
- HFCL Limited4.7% · ₹15.9 Cr
Exited Exited (7)
- Bata India Limitedwas 6.3% · ₹19.9 Cr
- Gillette India Limitedwas 5.2% · ₹16.4 Cr
- Titan Company Limitedwas 3.2% · ₹10 Cr
- Hindustan Unilever Limitedwas 2.1% · ₹6.5 Cr
- Bajaj Finserv Limitedwas 1.1% · ₹3.4 Cr
- Bajaj Finance Limitedwas 1.0% · ₹3.3 Cr
- Wipro Limitedwas 0.6% · ₹2 Cr
Biggest additions
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jul 2024, the weight rose most in Pharmaceuticals & Biotechnology (+7.2 pts) and Telecom - Services (+6.2 pts), and fell most in Consumer Durables (−10.2 pts) and Personal Products (−5.6 pts).
- Pharmaceuticals & Biotechnology32.3% → 39.6%+7.2 pts
- Telecom - Services0.0% → 6.2%new+6.2 pts
- Food Products15.8% → 19.7%+3.9 pts
- Insurance17.5% → 19.4%+1.8 pts
- Retailing8.0% → 9.1%+1.1 pts
- Agricultural Food & Other Products5.5% → 6.1%+0.6 pts
- Consumer Durables10.2% → 0.0%exited−10.2 pts
- Personal Products5.6% → 0.0%exited−5.6 pts
- Finance2.3% → 0.0%exited−2.3 pts
- Diversified FMCG2.2% → 0.0%exited−2.2 pts
- IT - Software0.7% → 0.0%exited−0.7 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Aug 2021 | Aug 2023 | Feb 2024 | May 2024 | Jul 2024 | Aug 2024 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | — | 8.0% | 8.0% | 18.4% | 32.3% | 39.6% |
| Food Products | — | — | 13.0% | 10.6% | 15.8% | 19.7% |
| Insurance | 7.3% | — | 8.6% | 5.6% | 17.5% | 19.4% |
| Retailing | — | — | — | 8.4% | 8.0% | 9.1% |
| Telecom - Services | — | — | — | — | — | 6.2% |
| Agricultural Food & Other Products | — | — | — | 4.7% | 5.5% | 6.1% |
Allocation in Aug 2024change vs Jul 2024
- Pharmaceuticals & Biotechnology (4)39.6%▲ 7.2 pts
- Food Products (2)19.7%▲ 3.9 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Aug 2024
15.0%
▲ 13.3 pts vs Jul 2024
- Cash alone
- 15.0%
- cash and net receivables
- A year earlier
- 17.8%
- Aug 2023 · now ▼ 2.8 pts
- Last 12 months
- 0.7% – 15.0%
- lowest to highest · record 17.8% in Aug 2023
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.